Christopher J. Joyce - 09 Mar 2023 Form 4 Insider Report for AdaptHealth Corp. (AHCO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Mar 2023, 18:18:32 UTC
Prior SEC filing
02 Mar 2023
Next SEC filing
07 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher Joyce

Key filing fact

Christopher J. Joyce filed Form 4 for AdaptHealth Corp. (AHCO) on 13 Mar 2023.

Key facts

  • This page summarizes Christopher J. Joyce's Form 4 filing for AdaptHealth Corp. (AHCO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Mar 2023, 18:18.

Change

  • Previous filing in this sequence was filed on 02 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AHCO transaction

Common Stock

Award

Transaction value
$0
Shares
+27,578
Change %
+31%
Price
$0.000000
Shares after
117,671
Date
09 Mar 2023
Ownership
Direct
Footnotes
F1
AHCO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
106,071
Date
09 Mar 2023
Ownership
See footnote
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares represent restricted stock units and will be settled in common stock upon vesting.

Footnote F2

Securities held directly by Mayaid2001 LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .